NCT04395183View on ClinicalTrials.gov

5-HTP and Creatine for Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

August 1, 2023

Study Completion Date

March 1, 2024

Conditions
Major Depressive Disorder
Interventions
DRUG

5-Hydroxytryptophan 100 MG

5-HTP 100mg PO BID

DRUG

Creatine monohydrate

Creatine monohydrate 5g PO qday

DRUG

placebo matched to 5-HTP

placebo matched to 5-HTP

DRUG

Placebo

Dextrose either as loose powder (matched to creatine) or encapsulated (matched to 5-HTP)

Trial Locations (1)

84108

University of Utah Department of Psychiatry, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT04395183 - 5-HTP and Creatine for Depression | Biotech Hunter | Biotech Hunter